Form 4: Regeneron EVP Neil Stahl Sells Shares and Gifts Stock
SEC Form 4
Neil Stahl, EVP of Research and Development at Regeneron Pharmaceuticals, sold shares of common stock on August 8, 2024, and gifted shares on August 12, 2024.
Summary
- Neil Stahl, an Executive Vice President at Regeneron Pharmaceuticals, reported the sale of company stock on August 8, 2024.
- The sales were executed in multiple transactions at varying prices, ranging from $1,081.75 to $1,086.16 per share.
- A total of 5,297 shares were sold on August 8, 2024.
- On August 12, 2024, Mr. Stahl gifted 900 shares of common stock.
- Following these transactions, Mr. Stahl directly owns 50,099 shares of Regeneron stock.
- He also indirectly owns 5,849 shares through a 401(k) plan and 4,605 shares held by his spouse as trustee.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting stock sales and a gift by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Executive stock transactions are a normal part of corporate governance. The sale and gifting of shares by an executive may be due to a variety of personal financial planning reasons and does not necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 08/08/2024 | Sale of Regeneron common stock. |
| 08/12/2024 | Gift of Regeneron common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.